U.S. Officials Approve Alzheimer’s Drug, Opening Access for Medicare Coverage
In a significant development for Alzheimer’s patients and their families, U.S. officials have granted full approval to a highly anticipated drug called Leqembi. This decision paves the way for Medicare…